Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

Cited by (1,001)

Items 801–900 of 1,001

  1. The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda
    Isaac Ssewanyana, Chris A. R. Baker, Theodore Ruel, Stephanie Bousheri, Moses Robert Kamya, Grant Dorsey, Philip Jon Rosenthal, Edwin D. Charlebois, Diane V. Havlir, Huyen Cao · 2009 · AIDS Research and Human Retroviruses
  2. Immunological intervention in human diseases
    Hideki Ueno, Catherine M. Hawrylowicz, Jacques Banchereau · 2007 · Journal of Translational Medicine
  3. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C
    Juan Ramon Larrubia, Selma Benito Martínez, Joaquín Miquel, Miryam Calvino, Eduardo Sanz‐de‐Villalobos, Trinidad Parra-Cid · 2009 · World Journal of Gastroenterology
  4. Inhibitory Signals Mediated by Programmed Death‐1 Are Involved With T‐Cell Function in Chronic Periodontitis
    Eduardo Aleixo Figueira, Maria Lúcia Rubo de Rezende, Sérgio Aparecido Torres, Gustavo Pompermaier Garlet, Vanessa Soares Lara, Carlos Ferreira Santos, Mário Júlio Ávila-Campos, João S. Silva, Ana Paula Campanelli · 2009 · Journal of Periodontology
  5. Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek’s disease virus
    Ayumi Matsuyama-Kato, Shiro Murata, Masayoshi Isezaki, Rika Kano, Sarah Takasaki, Osamu Ichii, Satoru Konnai, Kazuhiko Ohashi · 2012 · Virology Journal
  6. The Role of Caveolin 1 in HIV Infection and Pathogenesis
    Ayalew Mergia · 2017 · Viruses
  7. In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration
    Laurent Derré, Marc Bruyninx, Petra Baumgaertner, Estelle Devêvre, Patricia Corthésy, Cédric Touvrey, Yolanda D. Mahnke, Hanspeter Pircher, Verena Voelter, Pedro J. Romero et al. · 2007 · The Journal of Immunology
  8. Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model
    Mengji Lu, Stephan Menne, Dongliang Yang, Yang Y. Xu, Michael Roggendorf · 2007 · Expert Opinion on Investigational Drugs
  9. Dendritic cells at the interface of innate and adaptive immunity to HIV-1
    Anna Smed‐Sörensen, Karin Loré · 2011 · Current Opinion in HIV and AIDS
  10. A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to Mycobacterium tuberculosis and Co-Infection with HIV
    Nguyễn Đức Huy, Nicky Gazy, Vishwanath Venketaraman · 2020 · International Journal of Molecular Sciences
  11. Shocking HIV-1 with immunomodulatory latency reversing agents
    Anna Kula, Anthony Rodari, Gilles Darcis, Carine M. Van Lint · 2021 · Seminars in Immunology
  12. PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques
    Vijayakumar Velu, Kehmia Titanji, Hasan Ahmed, Ravi Dyavar Shetty, Lakshmi S. Chennareddi, Gordon James Freeman, Rafi Ahmed, Rama Rao Amara · 2022 · Proceedings of the National Academy of Sciences
  13. Mapping the interplay between NK cells and HIV: therapeutic implications
    Renee R. Anderko, Robbie B. Mailliard · 2023 · Journal of Leukocyte Biology
  14. Anti–PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers
    Karsten Eichholz, Yoshinori Fukazawa, Christopher W. Peterson, Françoise Haeseleer, Manuel Medina, Shelby T. Hoffmeister, Derick M. Duell, Benjamin D. Varco-Merth, Sandra Dross, Haesun Park et al. · 2024 · Journal of Clinical Investigation
  15. Translating insights from persistent LCMV infection into anti-HIV immunity
    Elizabeth B. Wilson, David G. Brooks · 2010 · Immunologic Research
  16. Salmonella Modulates B Cell Biology to Evade CD8+ T Cell-Mediated Immune Responses
    Marcela López‐Medina, Araceli Pérez-López, Celia Mercedes Alpuche-Aranda, Vianney Francisco Ortiz-Navarrete · 2014 · Frontiers in Immunology
  17. Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica.
    Yohann White, R B Pierre, J Steel-Duncan, P Palmer, Tracy Evans-Gilbert, J Moore, B Rodriguez, C D C Christie · 2008 · PubMed
  18. Survival and Proliferation of CD28- T Cells During HIV-1 Infection Relate to the Amplitude of Viral Replication
    Nancy Vivar, Nicolas Ruffin, Stefano Sammicheli, Bo Hejdeman, Bence Réthi, Francesca Chiodi · 2011 · The Journal of Infectious Diseases
  19. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions
    Tatiana M. García-Bates, Mariana L. Palma, Chengli Shen, Andrea A. Gambotto, Bernard J. C. Macatangay, Robert Louis Ferris, Charles R. Rinaldo, Robbie B. Mailliard · 2018 · Journal of Virology
  20. Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8 + T Cell Exhaustion Marker Expression
    Rachel Lena Rutishauser, Wendy Hartogensis, Christian Deo T. Deguit, Melissa Krone, Rebecca Hoh, Frederick M. Hecht, Christopher D. Pilcher, Peter Bacchetti, Steven G. Deeks, Peter W. Hunt et al. · 2017 · AIDS Research and Human Retroviruses
  21. Induction of Tolerance in CD8+ T Cells to a Transgenic Autoantigen Expressed in the Liver Does Not Require Cross-Presentation
    Junko O. Morimoto, Xiaoxio Tan, Ryan M. Teague, Claes Öhlén, Philip D. Greenberg · 2007 · The Journal of Immunology
  22. Vaccine and immunotherapeutic interventions
    Giuseppe Pantaleo, Yves Lévy · 2013 · Current Opinion in HIV and AIDS
  23. Therapeutic roles of CAR T cells in infectious diseases: Clinical lessons learnt from cancer
    Mahsa Mohammadi, Maryam Akhoundi, Sara Malih, Ali Mohammadi, Mohsen Sheykhhasan · 2022 · Reviews in Medical Virology
  24. Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy
    Adel Benlahrech, A Yasmin, Samantha J. Westrop, A Coleman, Anna Herasimtschuk, Emma E. Page, Peter Kelleher, F Gotch, Nesrina Imami, Steven Patterson · 2012 · Clinical & Experimental Immunology
  25. Unique features of memory T cells in HIV elite controllers: a systems biology perspective
    Simone Gonçalves Fonseca, Francesco A. Procopio, Jean-Philippe Goulet, Bader Yassine‐Diab, Petronela Ancuța, Rafick‐Pierre Sékaly · 2011 · Current Opinion in HIV and AIDS
  26. Understanding B cell activation: from single molecule tracking, through Tolls, to stalking memory in malaria
    Susan K. Pierce · 2008 · Immunologic Research
  27. The woodchuck: A model for therapeutic vaccination against hepadnaviral infection
    Michael Roggendorf, Dongliang Yang, Mengji Lu · 2010 · Pathologie Biologie
  28. Cytotoxic CD4+ T-cells during HIV infection: Targets or weapons?
    Alexandra Sánchez-Martínez, Federico Perdomo-Celis, Liliana Acevedo-Sáenz, Marı́a Teresa Rugeles, Paula A. Velilla · 2019 · Journal of Clinical Virology
  29. Smoking and Human Immunodeficiency Virus 1 Infection Promote Retention of CD8+ T Cells in the Airway Mucosa
    Björn Corleis, Josalyn L. Cho, Samantha J. Gates, Alice H. Linder, Amy K. Dickey, Antonella C. Lisanti-Park, Abigail E. Schiff, Musie S Ghebremichael, Puja Kohli, Tilo Winkler et al. · 2021 · American Journal of Respiratory Cell and Molecular Biology
  30. Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV/SIV Infection
    Yuting Sun, Jing Xue · 2022 · Viruses
  31. Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo
    Narasimhan J. Venkatachari, William G. Buchanan, Velpandi Ayyavoo · 2008 · Virology
  32. Differentiation of Antigen-Specific T Cells with Limited Functional Capacity during Mycobacterium tuberculosis Infection
    Yun Hee Jeong, Bo‐Young Jeon, Sun-Hwa Gu, Sang-Nae Cho, Sung Jae Shin, Jun Chang, Sang‐Jun Ha · 2013 · Infection and Immunity
  33. Comparisons of Underlying Mechanisms, Clinical Efficacy and Safety Between Anti-PD-1 and Anti-PD-L1 Immunotherapy: The State-of-the-Art Review and Future Perspectives
    Yating Zhao, Liu Liu, Liang Weng · 2021 · Frontiers in Pharmacology
  34. IL-27 induces IFN/STAT1-dependent genes and enhances function of TIGIT+ HIVGag-specific T cells
    Jie Cheng, Timothy G. Myers, Callie Levinger, Princy N. Kumar, Jai Kumar, Bruktawit A. Goshu, Alberto Bosque, Marta Catálfamo · 2021 · iScience
  35. Immunotherapy for KSHV-associated diseases
    Kathryn Anne Lurain, Robert Yarchoan, Ramya Ramaswami · 2022 · Current Opinion in Virology
  36. PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection
    Wen Xiao, Long Feng Jiang, Xiao Zhao Deng, Dan Yan Zhu, Jia Ping Pei, Mao Lei Xu, Bing Jun Li, Chang Jun Wang, Jing Hai Zhang, Qi Zhang et al. · 2015 · Immunologic Research
  37. PD-1 Regulates T Cell Proliferation in a Tissue and Subset-Specific Manner During Normal Mouse Pregnancy
    Michelle T. Shepard, Elizabeth A. Bonney · 2013 · Immunological Investigations
  38. Increased Memory Differentiation Is Associated with Decreased Polyfunctionality for HIV but Not for Cytomegalovirus-Specific CD8+ T Cells
    the CAPRISA 002 Study Team, Catherine Riou, Florette Kathleen Treurnicht, Melissa-Rose Abrahams, Koleka Patience Mlisana, Michael K. P. Liu, Nilu P Goonetilleke, Richard A. Koup, Mario Roederer, Salim S. Abdool Karim et al. · 2012 · The Journal of Immunology
  39. Understanding Experimental LCMV Infection of Mice: The Role of Mathematical Models
    Gennady Alekseevich Bocharov, Jordi M. Argilaguet, Andreas Meyerhans · 2015 · Journal of Immunology Research
  40. Arcelis™ AGS-004 dendritic cell-based immunotherapy for HIV infection
    Jean‐Pierre Routy, Charles A. Nicolette · 2010 · Immunotherapy
  41. Lymphocyte Activation Gene-3 Expression Defines a Discrete Subset of HIV-Specific CD8 + T Cells That Is Associated with Lower Viral Load
    José Peña, Norman G. Jones, Stephanie Bousheri, David R. Bangsberg, Huyen Cao · 2013 · AIDS Research and Human Retroviruses
  42. Immunosuppressive Mechanisms During Viral Infectious Diseases
    Ghanashyam Sarikonda, Matthias G. von Herrath · 2010 · Methods in molecular biology
  43. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells
    Norma Ibón Rallón, Marcial García, Javier García‐Samaniego, Noelia Rodríguez, Alfonso Cabello, Clara Restrepo, Beatriz Álvarez, Rosa García, Miguel Górgolas, Jose Miguel Benito · 2017 · PLoS ONE
  44. Single-molecule techniques to quantify and genetically characterise persistent HIV
    Xiao Qian Wang, Sarah Palmer · 2018 · Retrovirology
  45. IL-17 and IL-22 production in HIV+ individuals with latent and active tuberculosis
    Kamakshi Prudhula Devalraju, Venkata Sanjeev Kumar Neela, Sharadambal Sunder Ramaseri, Arunabala Chaudhury, Abhinav Van, Siva Sai Krovvidi, Ramakrishna Vankayalapati, Vijaya Lakshmi Valluri · 2018 · BMC Infectious Diseases
  46. PD-1 Expression in HIV-Specific CD8+ T cells Before Antiretroviral Therapy Is Associated With HIV Persistence
    Yanina Ghiglione, César Trifone, Jimena Salido, Ajantha Rhodes, María Julia Ruiz, María L. Polo, Horacio Salomón, Natalia Laufer, Omar Gustavo Sued, Sharon R. Lewin et al. · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  47. Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck
    Anna D. Kosinska, Ejuan Zhang, Mengji Lu, Michael Roggendorf · 2010 · Hepatitis Research and Treatment
  48. Broad TCR Usage in Functional HIV-1-Specific CD8+ T Cell Expansions Driven by Vaccination during Highly Active Antiretroviral Therapy
    Hongbing Yang, Tao Dong, Emma L. Turnbull, Srin Ranasinghe, Beatrice Ondondo, Nilu P Goonetilleke, Nicola Winstone, Kati di Gleria, Paul Bowness, Christopher P. Conlon et al. · 2007 · The Journal of Immunology
  49. Preserving HIV-specific T cell responses
    Bernard J. C. Macatangay, Charles R. Rinaldo · 2014 · Current Opinion in HIV and AIDS
  50. Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection
    Guido Ferrari, Justin Pollara, Georgia D. Tomaras, Barton F. Haynes · 2016 · The Journal of Infectious Diseases
  51. Pembrolizumab Interferes with the Differentiation of Human FOXP3+–Induced T Regulatory Cells, but Not with FOXP3 Stability, through Activation of mTOR
    Varun Sasidharan Nair, Salman M. Toor, Ghina M. Taouk, Gerald Pfister, Khalid Ouararhni, Nehad M. Alajez, Eyad Elkord · 2019 · The Journal of Immunology
  52. Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection
    Wei Li, Fahim Syed, Richard Yu, Jing Yang, Ying Xia, Ryan F. Relich, Patrick M. Russell, Shanxiang Zhang, Mandana Khalili, Laurence Huang et al. · 2022 · Frontiers in Immunology
  53. Exercise to Prevent Accelerated Vascular Aging in People Living With HIV
    Raymond Jones, Austin T. Robinson, Lauren Brittany Beach, Merry L. Lindsey, Annet Kirabo, Antentor Othrell Hinton Jr., Kristine Mace Erlandson, Nathaniel D.M. Jenkins · 2024 · Circulation Research
  54. PD-1 blockade: A promising immunotherapy for HIV?
    Bernard J. C. Macatangay, Charles R. Rinaldo · 2009 · PubMed
  55. PD ‐1 modulates steady‐state and infection‐induced IL ‐10 production in vivo
    Cortez McBerry, Alexandra Dias, Nathaniel Shryock, Kristin Lampe, Fredy R. S. Gutierrez, Louis Boon, De’Broski R. Herbert, Júlio Aliberti · 2013 · European Journal of Immunology
  56. Activation and Expansion of CD8+ T Effector Cells in Patients with Chronic Graft-versus-Host Disease
    Bryan M. Grogan, Laura Tabellini, Barry E. Storer, T.E. Bumgarner, Cláudia Cáceres Astigarraga, Mary E.D. Flowers, Stephanie Joi Lee, Paul J. Martin, Edus Houston Warren, John A. Hansen · 2011 · Transplantation and Cellular Therapy
  57. Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors
    Risa Omori, Junichi Eguchi, Kazumasa Hiroishi, S. Ishii, Ayako Hiraide, Masashi Sakaki, Hiroyoshi Doi, Atsushi Kajiwara, Takayoshi Ito, Mari Kogo et al. · 2012 · Cancer Gene Therapy
  58. Enhancement of SIV-specific cell mediated immune responses by co-administration of soluble PD-1 and Tim-3 as molecular adjuvants in mice
    Lijun Xiao, Dimin Wang, Caijun Sun, Pingchao Li, Yi Jin, Liqiang Feng, Ling Chen · 2013 · Human Vaccines & Immunotherapeutics
  59. Immunosenescence of the CD8+ T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue, metabolism, and muscle in antiretroviral therapy-treated HIV-infected patients and controls
    Juliette Tavenier, Anne Langkilde, Thomas Huneck Haupt, Jens H. Henriksen, Frank Krieger Jensen, Janne Petersen, Ove Andersen · 2015 · BMC Immunology
  60. Negative Checkpoint Regulatory Molecule 2B4 (CD244) Upregulation Is Associated with Invariant Natural Killer T Cell Alterations and Human Immunodeficiency Virus Disease Progression
    Fareed Ahmad, Esaki Muthu Shankar, Yean Kong Yong, Hong Yien Tan, Gerrit Ahrenstorf, Roland Jacobs, Marie Larsson, Reinhold Ernst Schmidt, Adeeba Kamarulzaman, Abdul Wahid Ansari · 2017 · Frontiers in Immunology
  61. Visualizing the Immune System: Providing Key Insights into HIV/SIV Infections
    Jacob D. Estes, Roger Le Grand, Constantinos Petrovas · 2018 · Frontiers in Immunology
  62. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy
    Erin Beck, Irene C. M. Cortese · 2020 · Current Opinion in Virology
  63. CMTM6 as a master regulator of PD-L1
    Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani · 2022 · Cancer Immunology Immunotherapy
  64. Salmonella impairs CD8 T cell response through PD-1: PD-L axis
    Marcela López‐Medina, Ismael Carrillo‐Martin, Jessica P. Leyva‐Rangel, Celia Mercedes Alpuche-Aranda, Vianney Francisco Ortiz-Navarrete · 2015 · Immunobiology
  65. Salmonella induces PD-L1 expression in B cells
    Marcela López‐Medina, Araceli Pérez-López, Celia Mercedes Alpuche-Aranda, Vianney Francisco Ortiz-Navarrete · 2015 · Immunology Letters
  66. HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels
    Michael A. Eller, Marc Sam Opollo, Michelle Liu, Andrew D. Redd, Leigh Anne Eller, Cissy M Kityo, John Timothy Kayiwa, Oliver B Laeyendecker, Maria Joan Wawer, M. Milazzo et al. · 2014 · The Journal of Infectious Diseases
  67. Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness
    Chun‐Pu Lin, Pierre L. Levy, Astrid Alflen, Georgi Apriamashvili, Maarten Alexander Ligtenberg, David W. Vredevoogd, Onno B. Bleijerveld, Ferhat Alkan, Yuval Malka, Liesbeth Hoekman et al. · 2024 · Cancer Cell
  68. Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer
    Chin-King Looi, Lian Chee Foong, Felicia Fei‐Lei Chung, Alan Soo Beng Khoo, Ee-Mun Loo, Chee‐Onn Leong, Chun‐Wai Mai · 2023 · Cell Biology and Toxicology
  69. Immune Checkpoint Inhibitors and Infection: What Is the Interplay?
    M Papadakis, Ioannis Karniadakis, Nikolaos Mazonakis, Karolina Akinosoglou, Constantinos Tsioutis, Nikolaos A. Spernovasilis · 2023 · In Vivo
  70. HCV-core and NS3 antigens play disparate role in inducing regulatory or effector T cells in vivo: Implications for viral persistence or clearance
    Deepa Kolaseri Krishnadas, Wen Li, Rakesh K. Kumar, D. Lorne Tyrrell, Babita Agrawal · 2009 · Vaccine
  71. Recent developments in human immunodeficiency virus-1 latency research
    Chi Ngai Chan, Isabelle Dietrich, Margaret J. Hosie, Brian J. Willett · 2013 · Journal of General Virology
  72. Antigen sensitivity and T-cell receptor avidity as critical determinants of HIV control
    Victor Appay, María Candela Iglesias · 2011 · Current Opinion in HIV and AIDS
  73. The safety of anti PD-1 therapeutics for the treatment of melanoma
    Egle Ramelyte, Sabrina A. Hogan, Reinhard Dummer · 2016 · Expert Opinion on Drug Safety
  74. Immune Checkpoint Inhibitors in Melanoma and HIV Infection
    Antonio Marra, Giosuè Scognamiglio, Ilaria Peluso, Gerardo Botti, Celeste Fusciello, Amelia Filippelli, Paolo A. Ascierto, Stefano Pepe, Francesco Sabbatino · 2017 · The Open AIDS Journal
  75. Therapeutic HIV-1 vaccine
    Nabila Seddiki, Yves Lévy · 2018 · Current Opinion in HIV and AIDS
  76. Human Immunodeficiency Virus Type 1 Escapes from Interleukin-2-Producing CD4 + T-Cell Responses without High-Frequency Fixation of Mutations
    Richard Brad Jones, FengYun Yue, Xiao Xiao Jenny Gu, Diana V. Hunter, Shariq Mujib, Gabor T. Gyenes, Rosemarie D. Mason, Ruqaya Mohamed, Kelly S. MacDonald, Colin M Kovacs et al. · 2009 · Journal of Virology
  77. Unraveling the Role of PD-1/PD-L Interactions in Persistent Hepatotropic Infections: Potential for Therapeutic Application?
    Henry Radziewicz, Holly L. Hanson, Rafi Ahmed, Arash Grakoui · 2008 · Gastroenterology
  78. Latency Reversing Agents and the Road to an HIV Cure
    Tioka, Louis, Diez, Rafael Ceña, Sönnerborg, Anders, van de Klundert, Maarten · 2025 · Pathogens
  79. EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8+ T cells toward less-exhausted phenotypes
    Andrea Gramatica, Itzayana G. Miller, Adam R. Ward, Khan Farzana, Tyler J. Kemmer, Jared Weiler, Tan Thinh Huynh, Paul Zumbo, Andrew P. Kurland, Louise Leyre et al. · 2025 · Cell Reports
  80. Implications of Senescent T Cells for Cancer Immunotherapy
    Tetsuhiro Kasamatsu · 2023 · Cancers
  81. Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody
    Mengmeng Ji, J L Hu, Doudou Zhang, Bilian Huang, Shijie Xu, Na Jiang, Yuxin Chen, Yujiong Wang, Xilin Wu, Zhiwei Wu · 2024 · EMBO Molecular Medicine
  82. Programmed Death-1 & its Ligands: Promising Targets for Cancer Immunotherapy
    Rajeev Kumar Shrimali, John Edward Janik, Rasha Abu Eid, Mikayel Mkrtichyan, Samir N. Khleif · 2015 · Immunotherapy
  83. Rapid downregulation of programmed death‐1 and interferon‐γ‐inducible protein‐10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B
    Feng-Qin Hou, Xuejie Wu, Y. Wang, J. Chen, Y.‐Z. Liu, Yuanyuan Ren, Ge Song, Yuping Ding, Ming‐Whei Yu, G.‐Q. Wang · 2013 · Journal of Viral Hepatitis
  84. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia
    Rita Tendeiro Rego, Russell B. Foxall, António P. Baptista, Francisco Rodrigues Pinto, Rui Silva Soares, Rita Cavaleiro, Emília Valadas, Perpétua Gómes, Rui M. M. Victorino, Ana E. Sousa · 2012 · AIDS
  85. Immunotherapy of Murine Retrovirus-Induced Acquired Immunodeficiency by CD4 T Regulatory Cell Depletion and PD-1 Blockade
    Wen Li, William R. Green · 2011 · Journal of Virology
  86. The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of naïve CD4+ T cells
    Francesco Nicoli, Eleonora Gallerani, Fabio Sforza, Valentina Finessi, Mkunde Chachage, Christof Geldmacher, Aurelio Cafaro, Barbara Ensoli, Antonella Caputo, Riccardo Gavioli · 2017 · AIDS
  87. Alveolar Macrophage Dysfunction and Increased PD-1 Expression During Chronic SIV Infection of Rhesus Macaques
    Ruth Hunegnaw, Zuena Mushtaq, Gospel M Enyindah-Asonye, Tanya N. Hoang, Marjorie Robert-Guroff · 2019 · Frontiers in Immunology
  88. Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure
    Selena Viganó, Sara Bobisse, George Coukos, Matthieu Perreau, Alexandre Harari · 2020 · Frontiers in Immunology
  89. The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription
    Afam A. Okoye, Rémi Fromentin, Hiroshi Takata, Jessica H. Brehm, Yoshinori Fukazawa, Bryan E. Randall, Marion Pardons, Vincent W.‐F. Tai, Jun Tang, Jeremy V Smedley et al. · 2022 · PLoS Pathogens
  90. Finding Balance: T cell Regulatory Receptor Expression during Aging.
    Mary Cavanagh, Qian Qi, Cornelia M. Weyand, Jörg J. Goronzy · 2011 · Europe PMC (PubMed Central)
  91. Impact of γ‐chain cytokines on T cell homeostasis in HIV‐1 infection: therapeutic implications
    Marie‐Lise Gougeon, Francesca Chiodi · 2010 · Journal of Internal Medicine
  92. Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C
    Andrea Crosignani · 2016 · World Journal of Gastroenterology
  93. Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection
    Christian Deo T. Deguit, Michelle Hough, Rebecca Hoh, Melissa Krone, Christopher D. Pilcher, Jeffrey N. Martin, Steven G. Deeks, J M McCune, Peter W. Hunt, Rachel Lena Rutishauser · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  94. Preclinical Evaluation of HIV Eradication Strategies in the Simian Immunodeficiency Virus-Infected Rhesus Macaque: A Pilot Study Testing Inhibition of Indoleamine 2,3-Dioxygenase
    Richard M. Dunham, Shari N. Gordon, Monica Vaccari, Michael Piatak, Yong Huang, Steven G. Deeks, Jeffrey D. Lifson, Genoveffa Franchini, J M McCune · 2012 · AIDS Research and Human Retroviruses
  95. Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review
    K.P. Mishra, Mrinalini Singh, Deepika Saraswat, Lilly Ganju, Rajeev Kumar Varshney · 2022 · Viral Immunology
  96. Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+ cells in vivo
    Hanyu Pan, Xinyi Yang, Jing Wang, Huitong Liang, Zhengtao Jiang, Lin Zhao, Yanan Wang, Zhiming Liang, Xiaoting Shen, Qinru Lin et al. · 2023 · Virologica Sinica
  97. Interleukin‐10‐secreting T cells define a suppressive subset within the HIV‐1‐specific T‐cell population
    Eirik A. Torheim, Lishomwa C. Ndhlovu, Frank Olav Pettersen, Trine‐Lise Larsen, Aashish R. Jha, Knut Martin Torgersen, Dag Kvale, Douglas F. Nixon, Kjetil Taskén, Einar Martin Aandahl · 2009 · European Journal of Immunology
  98. CD4 + T cell–dependent and CD4 + T cell–independent cytokine-chemokine network changes in the immune responses of HIV-infected individuals
    Kelly B. Arnold, Gregory Lee Szeto, Galit Alter, Darrell J. Irvine, Douglas A. Lauffenburger · 2015 · Science Signaling
  99. Clinical Interventions in HIV Cure Research
    Thomas A. Rasmussen, Ole Schmeltz Søgaard · 2018 · Advances in experimental medicine and biology
  100. Assessment of TCR signal strength of antigen-specific memory CD8+ T cells in human blood
    Hanchih Wu, Ashley Witzl, Hideki Ueno · 2019 · Blood Advances